Risk Minimisation Materials

MabThera (rituximab) - Important safety information for patients (or for parents/legal guardians of paediatric patients) receiving MabThera for non-oncology indications

The information provided in this booklet should be discussed with patients (or parents/legal guardians of paediatric patients) by their healthcare professional during MabThera (rituximab) treatment. This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

For Healthcare Professionals